Healthcare - Press Releases

Date	Title	Company
16-Dec-2020	Teknova completes FDA notification for room temperature-stable viral transport medium	Teknova
16-Dec-2020	First patients dosed in Phase III trials evaluating Fasenra in hypereosinophilic syndrome, eosinophilic esophagitis and eosinophilic granulomatosis with polyangiitis	Fasenra
16-Dec-2020	World Health Organization and Out There Impact join forces to use the power of mobile to prevent the ongoing spread of COVID-19 as world awaits vaccine rollout	Out There Media
16-Dec-2020	PharmiWeb.jobs Welcomes Albion Rye Associates	PharmiWeb.Jobs
16-Dec-2020	Digital health: Peer-reviewed study reveals significant disparities in coverage and accuracy among symptom assessment apps	Ada Health
16-Dec-2020	Global Companion Diagnostics Market Size, Growth, COVID-19 impact Analysis to 2025	Market Data Forecast
16-Dec-2020	Global Cancer Immunotherapy Market Size, Growth, COVID-19 Analysis Report	Market Data Forecast
15-Dec-2020	Sensyne Health launches first digital health product in the U.S.	Sensyne Health
15-Dec-2020	Air Cargo Industry Improves its Readiness to Transport COVID-19 Vaccines, but More Collaboration is Required	Pharma.Aero
15-Dec-2020	Appian selected by Accenture as a core partner in the INTIENT network for life sciences	Appian
15-Dec-2020	Seagen Announces Positive CHMP Opinion for Tucatinib for the Treatment of Patients with Locally Advanced or Metastatic HER2-Positive Breast Cancer	Seagen Inc
15-Dec-2020	European Commission grants licence for inclisiran (Leqvio® ▼), a first-in-class siRNA cholesterol-lowering treatment	Novartis
15-Dec-2020	BAVENCIO® (avelumab) Receives Positive CHMP Opinion for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma	Merck and Pfizer
15-Dec-2020	Polyphor announces third positive Data Safety Monitoring Board (DSMB) recommendation to continue Phase III balixafortide FORTRESS study without modifications	Polyphor AG
15-Dec-2020	Biophytis Presents SARA-OBS study results at the Annual Conference of The Society on Sarcopenia, Cachexia and Wasting Disorders (SCWD)	Biophytis
15-Dec-2020	The number of Russians ready to be vaccinated against coronavirus has reached 42%, a FOM poll shows	Russian Direct Investment Fund (RDIF)
15-Dec-2020	COVID-19 has made little positive impact on public perceptions of pharma, report suggests	Takeda UK
15-Dec-2020	Janssen Receives Positive CHMP Opinion for SPRAVATO®▼ (Esketamine Nasal Spray) for the Rapid Reduction of Depressive Symptoms in a Psychiatric Emergency for Patients with Major Depressive Disorder	Janssen Pharmaceutical Companies of Johnson & Johnson
15-Dec-2020	European Commission grants licence for inclisiran (Leqvio® ▼), a first-in-class siRNA cholesterol-lowering treatment	Novartis
15-Dec-2020	MinervaX raises upsized EUR 47.4M (USD 57M) Series B to advance its novel Group B Streptococcus vaccine through mid-stage clinical trials	MinervaX